(Q63599919)
Statements
A Phase II Double-Blind Trial to Evaluate the Safety, Immunogenicity and Effect on Infant Immune Responses of a Single Dose of Tdap in Pregnant Women in Mali (English)
0 references
24 January 2019
0 references
24 January 2020
0 references
200
0 references
18 year
0 references
39 year
0 references